CheckMate 8HW
What it tests: Final overall survival of nivolumab + ipilimumab vs nivolumab or chemo in MSI-H/dMMR metastatic colorectal cancer
The week in oncology, in your inbox
The OncoAlert Newsletter goes to 10,000+ oncologists and cancer stakeholders: every week, and every day during the major congresses. Free, independent, GDPR-compliant and easy to leave.